Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene-Reference-Cited by-同舟云学术

Association of APOA5 and APOC3 Genetic Polymorphisms With Severity of Hypertriglyceridemia in Patients With Cutaneous T-Cell Lymphoma Treated With Bexarotene

Published:2018-12-01 Issue:12 Volume:154 Page:1424
ISSN:2168-6068
Container-title:JAMA Dermatology
language:en
Short-container-title:JAMA Dermatol

Author:

Cabello Irene¹,Alia Pedro²,Pintó Xavier¹,Muniesa Cristina³,Fernandez-de-Misa Ricardo⁴,Peñate Yerai⁵,Morillo Mercedes⁶,Perez-Farriols Amparo⁷,Estrach Teresa⁸,Izu Rosa⁹,Gallardo Fernando¹⁰,Román Concepción¹¹,Cervigón Iván¹²,Ortiz-Brugues Ariadna¹³,Ortiz-Romero Pablo L.¹⁴,Servitje Octavio³

Affiliation:

1. Cardiovascular Risk Unit, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain

2. Clinical Genetics Laboratory, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain

3. Dermatology Department, Hospital Universitari de Bellvitge, IDIBELL, Barcelona, Spain

4. Dermatology Department, Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain

5. Dermatology Department, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain

6. Dermatology Department, Hospital Universitario Virgen del Rocio, Sevilla, Spain

7. Dermatology Department, Hospital General Universitario de Valencia, Valencia, Spain

8. Dermatology Department, Hospital Clínic, IDIBAPS, Barcelona, Spain

9. Dermatology Department, Hospital Universitario de Basurto, Bilbao, Spain

10. Dermatology Department, Hospital del Mar, IMIM, Barcelona, Spain

11. Dermatology Department, Hospital Universitario de Salamanca, Salamanca, Spain

12. Dermatology Department, Hospital Nuestra Señora del Prado, Talavera, Spain

13. Dermatology Department, Hospital Arnau de Vilanova, Lleida, Spain

14. Dermatology Department, Hospital Universitario 12 de Octubre, Institute i+12, CIBERONC, Medical School, University Complutense, Madrid, Spain

Publisher

American Medical Association (AMA)

Subject

Dermatology

Reference29 articles.

1. U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma.;Scarisbrick;Br J Dermatol,2013

2. The utility of bexarotene in mycosis fungoides and Sézary syndrome.;Panchal;Onco Targets Ther,2015

3. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas.;Whittaker;Br J Dermatol,2003

4. Bexarotene in cutaneous T-cell lymphoma: third retrospective study of long-term cohort and review of the literature.;Quéreux;Expert Opin Pharmacother,2013

5. EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome.;Trautinger;Eur J Cancer,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bexarotene Induce Differentiation of Myeloid-Derived Suppressor Cells through Arg-1 Signalling Pathway;Transplantation Proceedings;2024-07

2. Effects of Body Mass Index on Hypertriglyceridemia Associated with Oral Bexarotene Therapy: A Post Hoc Analysis of an Open-Label Comparative Clinical Study of Combined Bexarotene and Phototherapy Versus Bexarotene Monotherapy for Japanese Patients with Cutaneous T-Cell Lymphoma;Drugs in R&D;2024-06

3. Three-dimensional chromatin landscapes in hepatocellular carcinoma associated with hepatitis B virus;Journal of Gastroenterology;2023-11-05

4. Impact of body mass index on the severity of bexarotene‐associated hypertriglyceridemia: A post hoc analysis of an open‐labeled clinical study of combined bexarotene and phototherapy in Japanese patients with cutaneous T‐cell lymphoma;The Journal of Dermatology;2023-04-11

5. Safety and efficacy of bexarotene for Japanese patients with cutaneous T‐cell lymphoma: Real‐world experience from post‐marketing surveillance;The Journal of Dermatology;2021-10-18